Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects
NCT01374139
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class
Conditions
Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)
Interventions
DRUG:
Bosutinib
DRUG:
Bosutinib
Sponsor
Pfizer